This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chandler, D. S. Articles by Lozano, G. Search for Related Content PubMed PubMed Citation Articles by Chandler, D. S. Articles by Lozano, G.

Genotoxic Stress Induces Coordinately Regulated Alternative Splicing of the p53 Modulators MDM2 and MDM4

¹ Center for Childhood Cancer, Columbus Children's Research Institute and Department of Pediatrics, The Ohio State University, Columbus, Ohio and ² Department of Molecular Genetics, Section of Cancer Genetics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas

Requests for reprints: Dawn S. Chandler, Center for Childhood Cancer, WA5023, Children's Research Institute, 700 Children's Drive, Columbus, OH 43205. Phone: 614-722-5598; Fax: 614-722-5895; E-mail: chandler{at}ccri.net.

The tumor suppressor protein p53 is a transcription factor that induces G₁ arrest of the cell cycle and/or apoptosis. The murine double-minute protein MDM2 and its homologue MDM4 (also known as MDMX) are critical regulators of p53. Altered transcripts of the human homologue of mdm2, MDM2, have been identified in human tumors, such as invasive carcinoma of the breast, lung carcinoma, and liposarcoma. MDM2 alternate forms act to negatively regulate the normal MDM2 gene product, thus activating p53. Although many reports have documented a plethora of tumor types characterized by MDM2 alternative transcripts, few have investigated the signals that might initiate alternative splicing. We have identified a novel role of these alternative MDM2 transcripts in the normal surveillance mechanism of the cell and in DNA damage response. We report that alternate forms of MDM2 are detected after UV irradiation. Furthermore, we show that mouse cells treated with UV are also characterized by alternative transcripts of mdm2, suggesting that this is an important and evolutionarily conserved mechanism for regulating the expression of MDM2/mdm2. An additional p53 regulator and mdm2 family member, MDM4, is likewise alternatively spliced following UV irradiation. By activating alternative splicing of both MDM2 and MDM4, yet another layer of p53 regulation is initiated by the cells in response to damage. A stepwise model for malignant conversion by which alternate forms of MDM2 and MDM4 place selective pressure on the cells to acquire additional alterations in the p53 pathway is herein proposed. (Cancer Res 2006; 66(19): 9502-8)

This article has been cited by other articles:

				E. L. Volk, L. Fan, K. Schuster, J. E. Rehg, and L. C. Harris The MDM2-A Splice Variant of MDM2 Alters Transformation In vitro and the Tumor Spectrum in Both Arf- and p53-Null Models of Tumorigenesis Mol. Cancer Res., June 1, 2009; 7(6): 863 - 869. [Abstract] [Full Text] [PDF]

				M. Wade and G. M. Wahl Targeting Mdm2 and Mdmx in Cancer Therapy: Better Living through Medicinal Chemistry? Mol. Cancer Res., January 1, 2009; 7(1): 1 - 11. [Abstract] [Full Text] [PDF]

				C. He, Z. Zuo, H. Chen, L. Zhang, F. Zhou, H. Cheng, and R. Zhou Genome-wide detection of testis- and testicular cancer-specific alternative splicing Carcinogenesis, December 1, 2007; 28(12): 2484 - 2490. [Abstract] [Full Text] [PDF]

				V. Filippov, M. Filippova, and P. J. Duerksen-Hughes The Early Response to DNA Damage Can Lead to Activation of Alternative Splicing Activity Resulting in CD44 Splice Pattern Changes Cancer Res., August 15, 2007; 67(16): 7621 - 7630. [Abstract] [Full Text] [PDF]